March 19, 2021 /

Webinar: Solid Biosciences Presents Safety & Efficacy Update (March 16, 2021)

On March 16, 2021, Solid Biosciences joined PPMD for a webinar to provide a safety and efficacy update on the ongoing IGNITE DMD phase I/II clinical study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy.

Posted on March 19, 2021

Join Our Mailing List